BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 18928670)

  • 1. Human papillomavirus testing for primary cervical cancer screening.
    Runowicz CD; Garozzo S
    Curr Oncol Rep; 2008 Nov; 10(6):533-7. PubMed ID: 18928670
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Detection of human papillomavirus DNA in routine cervical scraping samples: use for a national cervical cancer screening program in a developing nation.
    Othman N; Othman NH
    Asian Pac J Cancer Prev; 2014; 15(5):2245-9. PubMed ID: 24716964
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Australian women's needs and preferences for information about human papillomavirus in cervical screening.
    McCaffery K; Irwig L
    J Med Screen; 2005; 12(3):134-41. PubMed ID: 16156944
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chapter 13: Primary screening of cervical cancer with human papillomavirus tests.
    Franco EL
    J Natl Cancer Inst Monogr; 2003; (31):89-96. PubMed ID: 12807951
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of initial stream urine samples and cervical samples for detection of human papillomavirus.
    Hagihara M; Yamagishi Y; Izumi K; Miyazaki N; Suzuki T; Kato H; Nishiyama N; Koizumi Y; Suematsu H; Mikamo H
    J Infect Chemother; 2016 Aug; 22(8):559-62. PubMed ID: 27342077
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Relative Performance of HPV and Cytology Components of Cotesting in Cervical Screening.
    Schiffman M; Kinney WK; Cheung LC; Gage JC; Fetterman B; Poitras NE; Lorey TS; Wentzensen N; Befano B; Schussler J; Katki HA; Castle PE
    J Natl Cancer Inst; 2018 May; 110(5):501-508. PubMed ID: 29145648
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of self-collection devices for cytology and human papillomavirus DNA testing in cervical cancer screening.
    Bidus MA; Zahn CM; Maxwell GL; Rodriguez M; Elkas JC; Rose GS
    Clin Obstet Gynecol; 2005 Mar; 48(1):127-32. PubMed ID: 15725865
    [No Abstract]   [Full Text] [Related]  

  • 8. [Cervical cancer screning: from cytology to HPV testing].
    Wei LH
    Zhonghua Fu Chan Ke Za Zhi; 2019 May; 54(5):289-292. PubMed ID: 31154708
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HPV testing in cervical cytology practice: it's all about choice.
    Stoler MH
    Acta Cytol; 2005; 49(2):117-9. PubMed ID: 15839612
    [No Abstract]   [Full Text] [Related]  

  • 10. Human papillomavirus DNA testing for cervical cancer screening: practical aspects in developing countries.
    Belinson SE; Belinson JL
    Mol Diagn Ther; 2010 Aug; 14(4):215-22. PubMed ID: 20799763
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Overview of human papillomavirus-based and other novel options for cervical cancer screening in developed and developing countries.
    Cuzick J; Arbyn M; Sankaranarayanan R; Tsu V; Ronco G; Mayrand MH; Dillner J; Meijer CJ
    Vaccine; 2008 Aug; 26 Suppl 10():K29-41. PubMed ID: 18847555
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cervical cancer screening in the early post vaccine era.
    Waxman AG
    Obstet Gynecol Clin North Am; 2008 Dec; 35(4):537-48; vii. PubMed ID: 19061815
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HPV for cervical cancer screening (HPV FOCAL): Complete Round 1 results of a randomized trial comparing HPV-based primary screening to liquid-based cytology for cervical cancer.
    Ogilvie GS; Krajden M; van Niekerk D; Smith LW; Cook D; Ceballos K; Lee M; Gentile L; Gondara L; Elwood-Martin R; Peacock S; Stuart G; Franco EL; Coldman AJ
    Int J Cancer; 2017 Jan; 140(2):440-448. PubMed ID: 27685757
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Self-collection of vaginal specimens for human papillomavirus testing in cervical cancer prevention (MARCH): a community-based randomised controlled trial.
    Lazcano-Ponce E; Lorincz AT; Cruz-Valdez A; Salmerón J; Uribe P; Velasco-Mondragón E; Nevarez PH; Acosta RD; Hernández-Avila M
    Lancet; 2011 Nov; 378(9806):1868-73. PubMed ID: 22051739
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Randomized controlled trial of human papillomavirus testing versus Pap cytology in the primary screening for cervical cancer precursors: design, methods and preliminary accrual results of the Canadian cervical cancer screening trial (CCCaST).
    Mayrand MH; Duarte-Franco E; Coutlée F; Rodrigues I; Walter SD; Ratnam S; Franco EL;
    Int J Cancer; 2006 Aug; 119(3):615-23. PubMed ID: 16572425
    [TBL] [Abstract][Full Text] [Related]  

  • 16. HPV testing in liquid specimens.
    Geyer SJ
    Acta Cytol; 2006; 50(5):599-600. PubMed ID: 17017457
    [No Abstract]   [Full Text] [Related]  

  • 17. Adding human papillomavirus testing to cytology for primary cervical cancer screening: shooting first and asking questions later.
    Sawaya GF
    Ann Intern Med; 2008 Apr; 148(7):557-9. PubMed ID: 18378951
    [No Abstract]   [Full Text] [Related]  

  • 18. Urine-based HPV testing as a method to screen for cervical cancer.
    Fontenot HB
    Nurs Womens Health; 2015; 19(1):59-65. PubMed ID: 25690816
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interest of human papillomavirus DNA quantification and genotyping in paired cervical and urine samples to detect cervical lesions.
    Ducancelle A; Legrand MC; Pivert A; Veillon P; Le Guillou-Guillemette H; De Brux MA; Beby-Defaux A; Agius G; Hantz S; Alain S; Catala L; Descamps P; Postec E; Caly H; Charles-Pétillon F; Labrousse F; Lunel F; Payan C
    Arch Gynecol Obstet; 2014 Aug; 290(2):299-308. PubMed ID: 24622934
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Primary human papillomavirus testing in organized cervical screening.
    Dillner J
    Curr Opin Obstet Gynecol; 2013 Feb; 25(1):11-6. PubMed ID: 23299089
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.